News | November 07, 2024
Mitsui Chemicals invests in clinical kidney disease drug developer Rege Nephro
The company uses iPS cells to develop treatments for diseases relating to the kidney
The company uses iPS cells to develop treatments for diseases relating to the kidney
The Pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market
Revolf's infertility and miscarriage tests are a new technology that uses blood tests to detect neoself-antibodies
NUBEQA is currently indicated for the treatment of adult patients with mHSPC in combination with docetaxel and for non-metastatic castration-resistant prostate cancer (nmCRPC)
Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
H.coagulans is, unlike other general lactobacillus, characterized by spore formation, giving it resistance to acid and heat
Subscribe To Our Newsletter & Stay Updated
